1 |
钱桂生. 肺癌不同病理类型发病率的变化情况及其原因[J/CD]. 中华肺部疾病杂志(电子版), 2011, 4(1): 1-5.
|
2 |
任成山,白 莉,钱桂生. 慢性阻塞性肺疾病合并肺癌临床特征及新理念[J/CD]. 中华肺部疾病杂志(电子版), 2015, 8(2): 137-142.
|
3 |
赵邱煜,信 涛. 非小细胞肺癌脑膜转移治疗的研究进展[J]. 医学综述,2021, 27(02):303-307.
|
4 |
Hoffman PC, Mauer AM, Vokes EE. Lung cancer[J]. Lancet, 2000, 355(9202): 479-85.
|
5 |
Yoder LH. Lung cancer epidemiology[J]. Medsurg Nurs, 2006, 15(3): 171-174.
|
6 |
Chen W, Zheng R, Zeng H, et al. Epidemiology of lung cancer in China[J]. Thorac Cancer, 2015, 6(2): 209-15.
|
7 |
Keshamouni V, Arenberg D, Kalemkerian G. Lung Cancer Metastasis[M]. 2010.
|
8 |
茆春国,邓 波. 肺癌循环肿瘤细胞侵袭转移机制的研究进展[J].中国肺癌杂志,2020, 23(03): 189-195.
|
9 |
朱 丽,龚 波. 下调miR-4262抑制肺癌细胞A549转移潜能的机制[J].分子诊断与治疗杂志,2020, 12(10): 1375-1379.
|
10 |
郭梦玲,王熙才,陈 艳. 外泌体miRNA与肺癌的发生发展[J]. 中国肿瘤生物治疗杂志,2020, 27(04): 457-462.
|
11 |
余昌敏,张 丹,闵 明,等. 外泌体miRNA作为癌症早期诊断标志物的研究进展[J]. 中国免疫学杂志,2020, 36(22): 2786-2790.
|
12 |
Pencheva N, Tavazoie SF. Control of metastatic progression by microRNA regulatory networks[J]. Nature cell biology, 2013, 15(6): 546-554.
|
13 |
Tang Y, Tang Y, Cheng YS. miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial-mesenchymal transition and the Notch signaling pathway[J]. Sci Rep, 2017, 7: 38232.
|
14 |
张月朋,陈复辉. miR-34在非小细胞肺癌中研究进展[J]. 中华实用诊断与治疗杂志,2020, 34(06): 643-645.
|
15 |
刘 罡,毛重山. miR-34a靶向CD44对肺癌细胞干细胞表型的影响[J]. 中国老年学杂志,2019, 39(10): 2477-2480.
|
16 |
王鑫元,国 强,常哲瀚,等. 奥沙利铂通过调控P53、miR-34a抑制胃癌细胞的增殖[J]. 包头医学院学报,2020, 36(10): 67-70+121.
|
17 |
Li XJ, Zhang W, Xu K, et al. miR-34a promotes liver fibrosis in patients with chronic hepatitis via mediating Sirt1/p53 signaling pathway[J]. Pathol Res Pract, 2020,216(5): 152876.
|
18 |
梁 辰,王 萍,金由辛,等. p53/miR-34a调控网络在肿瘤中的作用[J]. 生命科学,2016, 28(04): 464-469.
|
19 |
Zhu H, Chang LL, Yan FJ, et al. AKR1C1 activates STAT3 to promote the metastasis of non-small cell lung cancer[J]. Theranostics, 2018, 8(3): 676-92.
|
20 |
Wang AS, Duan GX, Zhao CL, et al. Reduced RKIP expression levels are associated with frequent non-small cell lung cancer metastasis and STAT3 phosphorylation and activation[J]. Oncol Lett, 2017, 13(5): 3039-3045.
|
21 |
茹泽园. 肺癌细胞外泌体通过其携带的IL-6介导的STAT3途径诱导肌管萎缩的机制研究[D]. 华中科技大学,2019.
|
22 |
Chiang PK, Gordon RK, TAL J, et al. S-Adenosylmethionine and methylation[J]. Faseb J, 1996, 10(4): 471-480.
|
23 |
刘绍文. S-腺苷甲硫氨酸(SAMe)对人肝内胆管癌细胞系ICC-9810增殖及迁移能力的影响及作用机制[D]. 皖南医学院,2019.
|
24 |
Palmisano WA. DNA methylation markers and early recurrence in stage i lung cancer[J]. N Engl J Med, 2008, 358(11): 1118-1128.
|
25 |
孙东峰,田 辉,刘贤锡,等. 鸟氨酸脱羧酶和S-腺苷甲硫氨酸脱羧酶双反义腺病毒对肺癌增殖和侵袭抑制作用的研究[J]. 中华外科杂志,2008, 46(1): 61-64.
|
26 |
Torre LA, Siegel RL, Jemal A. Lung cancer statistics[J]. Adv Exp Med Biol, 2016, 893: 1-19.
|
27 |
Faure M. Lung cancer in Europe: turning the spotlight on the biggest cancer killer[J]. Eur Respir J, 2016, 47(1): 42-4.
|
28 |
范 伟. S-腺苷甲硫氨酸抑制非小细胞性肺癌增殖,侵袭,转移的机制[D]. 广州医科大学,2018.
|
29 |
宋伟祥,卢 伟. 腺苷蛋氨酸在肠癌肝转移患者化疗期间的护肝作用[J]. 肿瘤研究与临床,2011(12): 847-848.
|
30 |
刘 敏. S-腺苷甲硫氨酸脱羧酶基因表达与大肠癌关系的研究[D]. 山东大学,2006.
|
31 |
Zhang F, Wang B, Qin T, et al. IL-6 induces tumor suppressor protein tyrosine phosphatase receptor type D by inhibiting miR-34a to prevent IL-6 signaling overactivation[J]. Mol Cell Biochem, 2020, 473(1-2): 1-3.
|
32 |
Rokavec M, Oner MG, Li H, et al. IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis[J]. J Clin Invest, 2014, 124(4): 1853-1867.
|